Imugene Stock Quote IMU - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.048

Bid

0.048

Ask

0.049

Volume

6,792,224

0.048 Day's Range 0.049

0.039 52 Week Range 0.15

Market Cap

351.351M

Previous Close

0.049

Open

0.049

Last Trade

0.048

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

21,106,449

Shares Outstanding

7,319,810,809

Dividend Yield

PE Ratio

-2.45

Earnings Per Share (EPS)

-0.02

Revenue

4.97M

Net Profit

-149.68M

Sector

Biological Pds,ex Diagnstics

Industry

Biotechnology Animal & Plant

Website

www.imugene.com

Headquarters

Melbourne, Victoria, Aus

Founded

1986

Imugene Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker IMU. The last closing price for Imugene was AUD0.05. Over the last year, Imugene shares have traded in a share price range of AUD 0.039 to AUD 0.15.

Imugene currently has 7,319,810,809 shares outstanding. The market capitalization of Imugene is AUD358.67 million. Imugene has a price to earnings ratio (PE ratio) of -2.45.

RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform

Collaboration will explore trans-arterial delivery of Imugene’s CF33 oncolytic virus utilizing RenovoRx’s TAMP therapy platform. TAMP is expected to enable localized, targeted delivery of CF33...

Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer

New clinical trial supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc.Avelumab (BAVENCIO®) to be provided to Imugene for Phase 2 clinical study in HER-2 positive gastric or...

Imugene and Eureka Therapeutics Announce Strategic Collaboration to Accelerate Advancement of Oncolytic Virus and T-Cell Therapy in Solid Tumours

The Collaboration will evaluate Eureka’s anti-CD19 ARTEMIS® T-cell therapy in combination with Imugene’s CD19-expressing oncolytic virus onCARlytics in solid tumours Potential to address lack of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.001	-2.04081632653	0.049	0.051	0.047	18418320	0.04918379	DE
4	-0.011	-18.6440677966	0.059	0.059	0.047	25126765	0.0511292	DE
12	-0.007	-12.7272727273	0.055	0.081	0.047	21106449	0.05617254	DE
26	-0.062	-56.3636363636	0.11	0.1125	0.047	22046268	0.06407589	DE
52	-0.002	-4	0.05	0.15	0.039	29018839	0.08150898	DE
156	-0.422	-89.7872340426	0.47	0.625	0.039	23277518	0.16370673	DE
260	0.026	118.181818182	0.022	0.625	0.016	22210709	0.15773072	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
1TTThrive Tribe Technologies Ltd	AUD 0.002 (100.00%)	300k
OSLOOncoSil Medical Ltd	AUD 0.003 (50.00%)	82k
AZLOArizona Lithium Ltd	AUD 0.003 (50.00%)	1.01M
H2GGreenHy2 Ltd	AUD 0.006 (50.00%)	11.49M
ILAOIsland Pharmaceuticals Limited	AUD 0.059 (47.50%)	1.62M
ARVOCArtemis Resources Limited	AUD 0.001 (-50.00%)	250k
ASROAsra Minerals Ltd	AUD 0.001 (-50.00%)	8M
GENGenmin Limited	AUD 0.053 (-33.75%)	3.7M
EXTODExcite Technology Services Ltd	AUD 0.002 (-33.33%)	1.2M
ACWOCActinogen Medical Limited	AUD 0.007 (-30.00%)	258.07k
WCNWhite Cliff Minerals Limited	AUD 0.023 (9.52%)	111.74M
SYASayona Mining Limited	AUD 0.0305 (-4.69%)	55.11M
88E88 Energy Limited	AUD 0.002 (-20.00%)	38.58M
WCNOWhite Cliff Nickel	AUD 0.012 (33.33%)	33.36M
SIGSigma Healthcare Limited	AUD 2.055 (0.24%)	26.82M